Improving timely access to care for women with advanced stage breast cancer in Botswana
Context
In Botswana, 70% of cancers reported, where staging information is available, are diagnosed at advanced stages, severely limiting the impact of treatment and long-term survival. Advanced disease at presentation is multifactorial and hampered by delays in pathology turnaround times and consequent loss to follow-up. There are significant barriers to diagnosis and treatment in the country, including limited cancer services and a dearth of trained personnel. These barriers result in delayed diagnoses, with extended delays especially in regional sites. However, there is an equal need to increase support to women with advanced breast cancer by understanding and addressing patient fears, from the time of diagnosis throughout the cancer treatment cycle and beyond. This gap in information and support can affect treatment compliance; patients with advanced breast cancer often complete neoadjuvant chemotherapy, however, often decline the necessary surgery.
Established in 2018, the Botswana-Rutgers Partnership for Health (BRPH) is a collaborative research and training initiative between Botswana’s Ministry of Health and Wellness, University of Botswana and the Rutgers Global Health Institute. The partnership aims to help advance Botswana’s national program in cancer care and prevention; create joint research and training programs to improve cancer care and prevention; and create local, subspecialty medical and health professions training programs.
Project description
The Botswana-Rutgers Partnership for Health, administratively supported by the Botswana-Harvard AIDS Institute Partnership, was awarded a SPARC award in October 2019 as part of the Round 3 cohort of 11 grantees with their project “Improving timely access to care for women with advanced stage breast cancer in Botswana.”
The primary goal of the project is to improve timely access to care for women with advanced stage breast cancer through a multifaceted approach including: a focus on understanding the gaps in cancer care through focus group discussions and clinician questionnaires; the development of a patient navigation system; and the training of medical officers to perform fine and core needle biopsy procedures.